{"id":"d73723e7-42b7-5287-82ed-ab4e801a9c29","stable_key":"d96b230c-481b-535b-930c-04eb87ec7f02:s-allylcysteine-extract-no","predicate":"increases_tested","statement":"The randomized extract trial reported increased blood NO readout after 12 weeks.","claim_class":"observational","status":"source_derived_draft","evidence_grade":"ungraded","direction":"positive","is_public":true,"mechanism_event_id":"96868eb2-d783-5ce4-9deb-7262cd062582","mechanism_event_label":"Human formulation evidence is available, with ingredient attribution unresolved.","subject":{"id":"13629967-abbc-5be1-a2b4-1f25eb3368f1","slug":"optimized-aged-black-garlic-2023","display_name":"Optimized aged black garlic extract in the 2023 hypertension trial","entity_type_key":"chemical_species"},"object":{"id":"30ad189c-bcff-5ed9-bdf2-0eae7682fadb","slug":"human-aged-garlic-trial-no","display_name":"Blood NO readout in the optimized aged black garlic trial","entity_type_key":"cellular_process"},"evidence_count":1,"mechanism_event":{"id":"96868eb2-d783-5ce4-9deb-7262cd062582","stable_key":"d96b230c-481b-535b-930c-04eb87ec7f02:s-allylcysteine-extract-no-event","event_type":"observed_relationship","label":"Human formulation evidence is available, with ingredient attribution unresolved.","description":"The randomized extract trial reported increased blood NO readout after 12 weeks.","status":"provisional","compartment":null,"participants":[{"entity":{"id":"13629967-abbc-5be1-a2b4-1f25eb3368f1","slug":"optimized-aged-black-garlic-2023","display_name":"Optimized aged black garlic extract in the 2023 hypertension trial","entity_type_key":"chemical_species"},"role":"subject","stoichiometry":null,"state_label":"","sequence_order":0,"notes":""},{"entity":{"id":"30ad189c-bcff-5ed9-bdf2-0eae7682fadb","slug":"human-aged-garlic-trial-no","display_name":"Blood NO readout in the optimized aged black garlic trial","entity_type_key":"cellular_process"},"role":"target","stoichiometry":null,"state_label":"","sequence_order":1,"notes":""},{"entity":{"id":"8c2c295d-68b3-5e62-b1a7-00fcf915e3cc","slug":"s-allylcysteine","display_name":"S-allyl-L-cysteine / SAC","entity_type_key":"small_molecule"},"role":"context_participant","stoichiometry":null,"state_label":"","sequence_order":2,"notes":""},{"entity":{"id":"f2a6b7ab-ad41-5ada-8895-41d6ce42f4e4","slug":"nitric-oxide","display_name":"NO","entity_type_key":"small_molecule"},"role":"context_participant","stoichiometry":null,"state_label":"","sequence_order":3,"notes":""}]},"contexts":[{"dimension":"acting_entity","value_text":"optimized-aged-black-garlic-2023","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"dose","value_text":"Optimized aged black garlic extract providing 0.25 mg SAC/day","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"duration","value_text":"Twelve weeks","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"evidence_access","value_text":"Primary abstract","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"experimental_comparison","value_text":"Randomized triple-blind placebo-controlled extract trial","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"experimental_model","value_text":"Grade I hypertensive participants receiving antihypertensive treatment","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"interpretation_status","value_text":"Source-derived research curation; not independent primary verification","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"limitations","value_text":"SAC-standardized extract, not purified SAC. Background antihypertensives continued; reported blood NO is a study assay endpoint.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"nutrient_topic","value_text":"S-allylcysteine collection; species, compartment, exposure, co-substrates and manipulation remain explicit.","comparator":null,"unit":null,"notes":"","entity":{"slug":"s-allylcysteine","display_name":"S-allyl-L-cysteine / SAC","entity_type_key":"small_molecule"}},{"dimension":"organism","value_text":"Homo sapiens","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"plain_language","value_text":"Human formulation evidence is available, with ingredient attribution unresolved.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"primary_references","value_text":"[37686723] Antihypertensive Effects of an Optimized Aged Garlic Extract in Subjects with Grade I Hypertension and Antihypertensive Drug Therapy: A Randomized, Triple-Blind Controlled Trial. · 2023 · https://pubmed.ncbi.nlm.nih.gov/37686723/ · DOI 10.3390/nu15173691","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"route","value_text":"Oral","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"tissue_or_cell_type","value_text":"Grade I hypertensive participants receiving antihypertensive treatment","comparator":null,"unit":null,"notes":"","entity":null}],"evidence":[{"id":"04fb4eaa-7c62-5068-a698-8864487304a9","evidence_kind":"source_excerpt","locator":"Lines 437-444","start_line":437,"end_line":444,"excerpt":"## s-allylcysteine-extract-no\nHuman formulation evidence is available, with ingredient attribution unresolved.\nThe randomized extract trial reported increased blood NO readout after 12 weeks.\nModel: Grade I hypertensive participants receiving antihypertensive treatment\nLimitations: SAC-standardized extract, not purified SAC. Background antihypertensives continued; reported blood NO is a study assay endpoint.\nEvidence access: Primary abstract\n[37686723] Antihypertensive Effects of an Optimized Aged Garlic Extract in Subjects with Grade I Hypertension and Antihypertensive Drug Therapy: A Randomized, Triple-Blind Controlled Trial. · 2023 · https://pubmed.ncbi.nlm.nih.gov/37686723/ · DOI 10.3390/nu15173691\nStructured context: {\"organism\": \"Homo sapiens\", \"tissue_or_cell_type\": \"Grade I hypertensive participants receiving antihypertensive treatment\", \"dose\": \"Optimized aged black garlic extract providing 0.25 mg SAC/day\", \"duration\": \"Twelve weeks\", \"route\": \"Oral\", \"experimental_comparison\": \"Randomized triple-blind placebo-controlled extract trial\", \"acting_entity\": \"optimized-aged-black-garlic-2023\", \"interpretation_status\": \"Source-derived research curation; not independent primary verification\"}","model_system":"Grade I hypertensive participants receiving antihypertensive treatment","directness":"reported_statement","verification_status":"source_derived_draft","notes":"Original curation paraphrase; evidence access and experimental limitations specified.","relationship":"supports","weight":1.0,"link_notes":"","source":{"id":"3b0d58f9-8a69-579d-9920-518399a9a8bb","stable_key":"import-d96b230c-481b-535b-930c-04eb87ec7f02","title":"S-allylcysteine: sulfur signaling, redox responses and cross-nutrient mechanisms (2026-09-20)","document_type":"imported_text","citation_label":"AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text.","file_path":"","sha256":"91d7aeac82e42ce559d13dd8a2e0165d37760f7f555dd01c80e0604fa6e71ea2","revision_id":"545e497c-e5e3-543c-b26b-b297cbc7bbec","review_status":"unverified_draft","notes":""}}],"relations":[],"conflicts":[],"corrections":[],"research":null}